GSGTF   $3.1  -65.00% Market Closed

GENSIGHT BIOLOGICS SA
Total Cash 6.94M
totalCashPerShare 0.067
EBITDA -19.21M
Total Debt 22.68M
quickRatio 0.489
currentRatio 0.772
Total Revenue 1.98M
debtToEquity
Revenue/Share 0.03
ROA -0.78839
ROE
grossProfits
freeCashflow -8.39M
operatingCashflow -15.80M
earningsGrowth
revenueGrowth -0.364
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -4.28414
profitMargins 0.0
enterpriseValue 48.83M
forwardPE
floatShares 34.38M
sharesOutstanding 107.26M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.16%
heldPercentInstitutions 0.21%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.24
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -20.11M
trailingEps -0.38%
forwardEps
enterpriseToEbitda -2.54
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 7
lastUpdated Nov. 7, 2024, 2:44 a.m.